Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 1
1978 1
1980 1
1981 2
1983 3
1984 4
1985 4
1986 2
1987 6
1988 5
1989 5
1990 8
1991 5
1992 4
1993 2
1994 8
1995 8
1996 11
1997 8
1998 20
1999 17
2000 10
2001 15
2002 15
2003 23
2004 29
2005 24
2006 14
2007 20
2008 21
2009 15
2010 19
2011 12
2012 11
2013 12
2014 3
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Results by year

Filters applied: . Clear all
Page 1
Reduced exposure to calcineurin inhibitors in renal transplantation.
Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF; ELITE-Symphony Study. Ekberg H, et al. Among authors: vanrenterghem y. N Engl J Med. 2007 Dec 20;357(25):2562-75. doi: 10.1056/NEJMoa067411. N Engl J Med. 2007. PMID: 18094377 Free article. Clinical Trial.
Pre-emptive kidney transplantation.
Vanrenterghem Y, Verberckmoes R. Vanrenterghem Y, et al. Nephrol Dial Transplant. 1998 Oct;13(10):2466-8. doi: 10.1093/ndt/13.10.2466. Nephrol Dial Transplant. 1998. PMID: 9794542 Review. No abstract available.
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP. Vincenti F, et al. Among authors: vanrenterghem y. Am J Transplant. 2010 Mar;10(3):535-46. doi: 10.1111/j.1600-6143.2009.03005.x. Am J Transplant. 2010. PMID: 20415897 Free article. Clinical Trial.
Tailoring immunosuppressive therapy.
Kuypers DR, Vanrenterghem YC. Kuypers DR, et al. Among authors: vanrenterghem yc. Nephrol Dial Transplant. 2002 Dec;17(12):2051-4. doi: 10.1093/ndt/17.12.2051. Nephrol Dial Transplant. 2002. PMID: 12454210 Review. No abstract available.
Immunosuppression: does one regimen fit all?
Sprangers B, Kuypers DR, Vanrenterghem Y. Sprangers B, et al. Among authors: vanrenterghem y. Transplantation. 2011 Aug 15;92(3):251-61. doi: 10.1097/TP.0b013e31822094d1. Transplantation. 2011. PMID: 21593703 Review.
Tacrolimus (FK 506) in kidney transplantation.
Vanrenterghem Y. Vanrenterghem Y. Transplant Proc. 1998 Aug;30(5):2171-3. doi: 10.1016/s0041-1345(98)00578-8. Transplant Proc. 1998. PMID: 9723431 Review. No abstract available.
Anemia after kidney transplantation.
Vanrenterghem Y. Vanrenterghem Y. Transplantation. 2009 May 15;87(9):1265-7. doi: 10.1097/TP.0b013e3181a170b7. Transplantation. 2009. PMID: 19424022
Prophylaxis of cytomegalovirus infection in renal transplantation.
Kuypers DR, Vanrenterghem Y. Kuypers DR, et al. Among authors: vanrenterghem y. Nephrol Dial Transplant. 1998 Dec;13(12):3012-6. doi: 10.1093/ndt/13.12.3012. Nephrol Dial Transplant. 1998. PMID: 9870456 Review. No abstract available.
Bartter's and Gitelman's syndromes: from gene to clinic.
Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Naesens M, et al. Among authors: vanrenterghem y. Nephron Physiol. 2004;96(3):p65-78. doi: 10.1159/000076752. Nephron Physiol. 2004. PMID: 15056980 Review.
354 results